Bosentan and Macitentan Prevent the Endothelial-To-Mesenchymal Transition (EndoMT) in Systemic Sclerosis: In Vitro Study

Arthritis Research & Therapy
doi 10.1186/s13075-016-1122-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Mechanisms of Endothelial to Mesenchymal Cell Transition (EndoMT) in Experimentally Induced Fibrotic Diseases

Fibrogenesis and Tissue Repair
DermatologyMedicineHepatologyRheumatologyGastroenterology
2012English

Endothelial-To-Mesenchymal Transition in Pulmonary Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2015English

Bosentan Is Effective Against Digital Ulcerations and Hyperkeratosis in Systemic Sclerosis

Acta Dermato-Venereologica
DermatologyMedicine
2011English

Inflammation-Induced Endothelial to Mesenchymal Transition Promotes Brain Endothelial Cell Dysfunction and Occurs During Multiple Sclerosis Pathophysiology

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Endothelial-Mesenchymal Transition in Atherosclerotic Lesion Calcification

Atherosclerosis
Cardiovascular MedicineCardiology
2016English

Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction Between Inflammation and Endothelial Dysfunction

Frontiers in Immunology
AllergyImmunology
2018English

The Role of Endothelial-Mesenchymal Transition in Heterotopic Ossification

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2012English

The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis

Current Rheumatology Reviews
Rheumatology
2019English

Bone Marrow Endothelial Progenitors Are Defective in Systemic Sclerosis

Arthritis & Rheumatism
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy